- Home
- SRAD vs CORT Comparison
SRAD vs CORT Comparison
Compare SRAD & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRAD
- CORT
- Stock Information
- Founded
- SRAD 2001
- CORT 1998
- Country
- SRAD Switzerland
- CORT United States
- Employees
- SRAD N/A
- CORT N/A
- Industry
- SRAD Computer Software: Programming Data Processing
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- SRAD Technology
- CORT Health Care
- Exchange
- SRAD Nasdaq
- CORT Nasdaq
- Market Cap
- SRAD 5.2B
- CORT 5.6B
- IPO Year
- SRAD 2021
- CORT N/A
- Fundamental
- Price
- SRAD $20.04
- CORT $55.31
- Analyst Decision
- SRAD Strong Buy
- CORT Strong Buy
- Analyst Count
- SRAD 10
- CORT 4
- Target Price
- SRAD $16.90
- CORT $75.25
- AVG Volume (30 Days)
- SRAD 961.6K
- CORT 791.4K
- Earning Date
- SRAD 11-07-2024
- CORT 02-13-2025
- Dividend Yield
- SRAD N/A
- CORT N/A
- EPS Growth
- SRAD N/A
- CORT 57.97
- EPS
- SRAD 0.20
- CORT 1.26
- Revenue
- SRAD $1,173,401,739.00
- CORT $628,555,000.00
- Revenue This Year
- SRAD $26.93
- CORT $46.29
- Revenue Next Year
- SRAD $13.73
- CORT $17.09
- P/E Ratio
- SRAD $98.14
- CORT $43.87
- Revenue Growth
- SRAD 26.55
- CORT 39.67
- 52 Week Low
- SRAD $9.17
- CORT $20.84
- 52 Week High
- SRAD $20.90
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- SRAD 76.56
- CORT 58.22
- Support Level
- SRAD $17.61
- CORT $49.00
- Resistance Level
- SRAD $20.90
- CORT $52.17
- Average True Range (ATR)
- SRAD 0.83
- CORT 1.76
- MACD
- SRAD 0.20
- CORT 0.52
- Stochastic Oscillator
- SRAD 78.74
- CORT 99.21
About SRAD Sportradar Group AG
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.